These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25125013)

  • 1. Switching from ticagrelor to prasugrel: a warning.
    Parodi G; Bellandi B; Antoniucci D
    Int J Cardiol; 2014 Oct; 176(3):1089-90. PubMed ID: 25125013
    [No Abstract]   [Full Text] [Related]  

  • 2. Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.
    Deharo P; Bassez C; Bonnet G; Pankert M; Quilici J; Lambert M; Verdier V; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Int J Cardiol; 2013 Dec; 170(2):e21-2. PubMed ID: 24231059
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.
    Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos KC; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
    Circ Cardiovasc Interv; 2012 Dec; 5(6):797-804. PubMed ID: 23169985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.
    Lhermusier T; Voisin S; Murat G; Mejean S; Garcia C; Bataille V; Lipinski MJ; Carrié D; Sié P
    Int J Cardiol; 2014 Jul; 174(3):874-6. PubMed ID: 24820749
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.
    Parodi G; Valenti R; Bellandi B; Migliorini A; Marcucci R; Comito V; Carrabba N; Santini A; Gensini GF; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2013 Apr; 61(15):1601-6. PubMed ID: 23500251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
    Bagai A; Wang Y; Wang TY; Curtis JP; Gurm HS; Shah B; Cheema AN; Peterson ED; Saucedo JF; Granger CB; Roe MT; Bhatt DL; McNamara RL; Alexander KP
    Circ Cardiovasc Interv; 2014 Aug; 7(4):585-93. PubMed ID: 25097196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.
    Ferreiro JL; Ueno M; Tello-Montoliu A; Tomasello SD; Seecheran N; Desai B; Rollini F; Guzman LA; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2013 Feb; 6(2):182-4. PubMed ID: 23428011
    [No Abstract]   [Full Text] [Related]  

  • 8. Switching from clopidogrel to prasugrel in patients having coronary stent implantation.
    Parodi G; De Luca G; Bellandi B; Comito V; Valenti R; Marcucci R; Carrabba N; Migliorini A; Ramazzotti RN; Gensini GF; Abbate R; Antoniucci D
    J Thromb Thrombolysis; 2014 Oct; 38(3):395-401. PubMed ID: 24659131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of a subacute stent thrombosis in a prasugrel resistant patient successfully managed with ticagrelor.
    Fiore M; Horovitz A; Pons AC; Leroux L; Casassus F
    Platelets; 2014; 25(8):636-8. PubMed ID: 24245489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2).
    Angiolillo DJ; Curzen N; Gurbel P; Vaitkus P; Lipkin F; Li W; Jakubowski JA; Zettler M; Effron MB; Trenk D
    J Am Coll Cardiol; 2014 Apr; 63(15):1500-9. PubMed ID: 24333493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching acute coronary syndrome patients from prasugrel to clopidogrel.
    Kerneis M; Silvain J; Abtan J; Cayla G; O'Connor SA; Barthélémy O; Vignalou JB; Beygui F; Brugier D; Martin R; Collet JP; Montalescot G
    JACC Cardiovasc Interv; 2013 Feb; 6(2):158-65. PubMed ID: 23428007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving pattern of on-prasugrel and on-ticagrelor platelet reactivity over time in ST elevation myocardial infarction patients.
    Alexopoulos D; Xanthopoulou I; Siapika A; Tsoni E; Stavrou K; Theodoropoulos KC; Davlouros P
    Int J Cardiol; 2013 Sep; 168(1):629-30. PubMed ID: 23434008
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticagrelor vs prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events.
    Alexopoulos D; Stavrou K; Koniari I; Gkizas V; Perperis A; Kontoprias K; Vogiatzi C; Bampouri T; Xanthopoulou I
    Thromb Haemost; 2014 Sep; 112(3):551-7. PubMed ID: 24990396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prasugrel--oral (Efient)].
    J Pharm Belg; 2010 Dec; (4):131-2. PubMed ID: 21298816
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation.
    Huang PH; Croce KJ; Bhatt DL; Resnic FS
    Crit Pathw Cardiol; 2012 Dec; 11(4):177-85. PubMed ID: 23149359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects during the transition between cangrelor and prasugrel.
    Schneider DJ; Seecheran N; Raza SS; Keating FK; Gogo P
    Coron Artery Dis; 2015 Jan; 26(1):42-8. PubMed ID: 25089928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
    Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A
    J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization to prasugrel: cardiology's increased need for allergy consultation.
    Mutnick JL
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):124-5. PubMed ID: 22289733
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.
    Bonello L; Laine M; Cluzel M; Frere C; Mancini J; Hasan A; Thuny F; Gaubert M; Guieu R; Dignat-George F; Michelet P; Paganelli F; Kerbaul F
    Am J Cardiol; 2015 Aug; 116(3):339-43. PubMed ID: 26037292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor: the silence of the platelets.
    Laine M; Paganelli F; Bonello L
    Expert Opin Pharmacother; 2013 Feb; 14(2):151-3. PubMed ID: 23294190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.